openPR Logo
Press release

Subcutaneous Biologics Market 2018 - Industry Analysis By Leading Key Players: Amgen, Inc., Eisai, Inc., AbbVie, Inc., Pfizer, Inc., Genentech Inc., Biogen Idec, F. Hoffmann-La Roche AG

06-03-2019 08:56 AM CET | Health & Medicine

Press release from: Coherent Market Insights (CMI)

Subcutaneous Biologics

Subcutaneous Biologics

In terms of geography, the global market for subcutaneous biologics is segmented into four major regions, namely, North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). There is huge healthcare spending in countries such as United States and Canada, and high prevalence of diseases such as rheumatoid arthritis and breast cancer. The Centers for Disease Control and Prevention (CDC) estimate that the current prevalence of rheumatoid arthritis (nearly 50 million Americans in 2012) will increase to 78 million by 2040. The disease also affects nearly 300,000 children in the U.S. according to RheumatoidArthritis.org. In the European region, EU-5 countries (Germany, France, United Kingdom, Italy and Spain) are the most potential market owing well established economy of these regions.

Get Free PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/74

Biologic, also known as biopharmaceutical, is a complex medicinal product manufactured by a biological process. Examples of biologics include blood and plasma derived products, vaccines, somatic cells and body proteins. Biologics market refers to a multibillion dollar opportunity that is expanding globally at an impressive growth rate. Most biologic products are given intravenously. However, in the past few years, a number of biologics have been developed that are given subcutaneously. The subcutaneous route of administration offers significant advantages over intravenous administration such as ease of drug administration, does not require skilled personnel for drug administration, enables at-home drug delivery and thus reduces patient time at healthcare facilities, reduced medicine cost and increased therapy compliance.

Owing to aforementioned factors, the subcutaneous route of administration has gained enormous traction in recent years. Subcutaneous route of drug administration are highly effective in administering biologics such as vaccines, proteins, peptides, antibodies and other large and complex molecules. The global market for subcutaneous biologics will be expanding under the influence of factors such as: Advantages over other routes of administration, Increasing trend of self-medication, Introduction of innovative drug delivery devices such as auto-injectors and prefilled syringes, Growing incidence and prevalence of rheumatoid arthritis and breast cancer, Growth in the biosimilars market,.

Free Request Sample of Report: www.coherentmarketinsights.com/insight/request-sample/74

Humira (Adalimumab), MabThera/Rituxan (Rituximab), Zytux (Rituximab), Stelara (ustekinumab), Enbrel (Etanercept)., Neulasta (filgrastim), ORENCIA (abatacept), RoACTEMRA (tocilizumab) and Herceptin (Trastuzumab) are among the major commercially available biologics that are administered through subcutaneous route. F. Hoffmann-La Roche AG announced the European Commission (EU) approval of its subcutaneous formulation of RoACTEMRA (tocilizumab) in April 2014. Amgen launched Neulasta delivery kit in 2015 to automate the delivery of drug and preventing infection in cancer patients.

Some of the major companies operating in the global subcutaneous biologics market include Genentech Inc., Biogen Idec, F. Hoffmann-La Roche AG, Amgen, Inc., Eisai, Inc., AbbVie, Inc., Pfizer Ltd., Takeda Pharmaceutical Company Ltd. and Bristol-Myers Squibb.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Subcutaneous Biologics Market 2018 - Industry Analysis By Leading Key Players: Amgen, Inc., Eisai, Inc., AbbVie, Inc., Pfizer, Inc., Genentech Inc., Biogen Idec, F. Hoffmann-La Roche AG here

News-ID: 1761921 • Views: 3803

More Releases from Coherent Market Insights (CMI)

Gems and Jewelry Market Covering Competitive Scenario & Market Dynamics througho …
Gems and jewelry consists of various jewelries that are made out of gold, platinum, gemstones, and others. Gems and jewelry is one of the fastest growing markets, as it holds customary values in several cultures across the globe. Several leading companies are aiming on investing in the marketing, advertising, and launching of new showrooms for increasing publicity and expanding their presence in the market. Get Sample Copy of This Premium
Security Paper Market : Global Industry Analysis, Trends, Market Size and Foreca …
Security paper is a paper which constitutes features that help qualify and identify a document as authentic or original. The use of security paper exemplifies the importance of a document and helps in distinguishing between authentic and counterfeit documents. It is widely used for printing currency, legal, and government documents. Get Sample Copy of This Premium Research (including full TOC, Tables and Figures)@ https://www.coherentmarketinsights.com/insight/request-sample/561 Counterfeiting of documents and currency has
Potato Processing Market Expected to Reach At a Highest Growth During Forecast P …
Potato is a starchy root vegetable, which is mainly obtained from the plant Solanum tuberosum. Potato tuber is widely processed to get a variety of food products such as chips, fries, flakes, and other convenience food. Potato is also processed for its application as filler, binder, and adhesive by various end-use industries such as paper, textile, and pharmaceuticals. Furthermore, processed potato is used in animal feed and biofuels as well.
Gelatin Market 2020 Size, Share, Development Status, Type and Application, Segme …
Gelatin is a soft protein comes from collagen obtained by boiling skin, tendons, ligaments, bones when dissolved with water. It is usually found in animal parts enriched with amino acids (as cows, pigs, and fish). This type of collagen gelatin usually helps to swallow capsules easily. According to varying sources of raw material and processing techniques, gelatin has its additional nutritional value. Gelatin is used for preparation of foods, cosmetics,

All 5 Releases


More Releases for Biologic

Biologic Injectors Market Insights, Forecast to 2028
Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases. Biologic injectors offer different methods of administration such as simple piston, gas, jet and others. They can also be used
Biologic and Medical Imaging Reagents: Global Healthcare Update 2018
Press Release – 10 Jan 2019 Research and Development News -- . . Latest Update "Biologic and Medical Imaging Reagents: Global Markets" with Industries Survey | Global Current Growth and Future. ' ' Report Highlights The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the
Biologic Therapeutics Market Insights & Outlook on Industry 2025
Global Biologic Therapeutics Market: Snapshot The branch of science that deals with manufacturing medicines and pharmaceutical products based on biological origins is called biological therapeutics. Any pharmaceutical drug product manufactured from semi-synthesized and biological sources is included under this field. Owing to rapid advances experienced by this sector, a distinct biologic therapeutics market has formed. This market is mainly being driven by a rising demand for better healthcare treatments occurring all
Biologic Therapeutics Market Geographical Outlook by 2025
Global Biologic Therapeutics Market: Overview The global biologic therapeutics market is predicted to benefit from the rising applications of biological products. Biological products could be made of sugars, nucleic acids, proteins, or complex combinations of these substances, or may be living components such as cells and tissues. Biological products are used to prevent diseases, diagnose diseases, or treat or cure medical conditions. Global Biologic Therapeutics Market: Key Trends and Opportunities First and foremost,
Human Hepatitis B Immunoglobulin (IM) Market 2017 - Shanghai RAAS, Hualan Biolog …
Apex Research, recently published a detailed market research study focused on the "Human Hepatitis B Immunoglobulin (IM) Market" across the global, regional and country level. The report provides 360° analysis of "Human Hepatitis B Immunoglobulin (IM) Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Hepatitis B Immunoglobulin (IM) industry, and
Global Biologic Drugs Sales Market Report 2017
In this report, the global Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast),